Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloride, Morphine
2. Contin, Ms
3. Duramorph
4. Morphia
5. Morphine
6. Morphine Chloride
7. Morphine Sulfate
8. Morphine Sulfate (2:1), Anhydrous
9. Morphine Sulfate (2:1), Pentahydrate
10. Ms Contin
11. Oramorph Sr
12. Sdz 202 250
13. Sdz 202-250
14. Sdz 202250
15. Sdz202 250
16. Sdz202-250
17. Sdz202250
18. Sulfate, Morphine
1. Morphine Sulfate
2. Schembl29317
3. Morphinesulfatenarcoticanalgesic
Molecular Weight | 383.4 g/mol |
---|---|
Molecular Formula | C17H21NO7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 383.10387318 g/mol |
Monoisotopic Mass | 383.10387318 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
3 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
4 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
5 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
6 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Morphine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Morphine Sulfate manufacturer or Morphine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Morphine Sulfate manufacturer or Morphine Sulfate supplier.
PharmaCompass also assists you with knowing the Morphine Sulfate API Price utilized in the formulation of products. Morphine Sulfate API Price is not always fixed or binding as the Morphine Sulfate Price is obtained through a variety of data sources. The Morphine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Di(morphine) dihydrogen sulfate pentahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Di(morphine) dihydrogen sulfate pentahydrate, including repackagers and relabelers. The FDA regulates Di(morphine) dihydrogen sulfate pentahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Di(morphine) dihydrogen sulfate pentahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Di(morphine) dihydrogen sulfate pentahydrate supplier is an individual or a company that provides Di(morphine) dihydrogen sulfate pentahydrate active pharmaceutical ingredient (API) or Di(morphine) dihydrogen sulfate pentahydrate finished formulations upon request. The Di(morphine) dihydrogen sulfate pentahydrate suppliers may include Di(morphine) dihydrogen sulfate pentahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Di(morphine) dihydrogen sulfate pentahydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Di(morphine) dihydrogen sulfate pentahydrate active pharmaceutical ingredient (API) in detail. Different forms of Di(morphine) dihydrogen sulfate pentahydrate DMFs exist exist since differing nations have different regulations, such as Di(morphine) dihydrogen sulfate pentahydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Di(morphine) dihydrogen sulfate pentahydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Di(morphine) dihydrogen sulfate pentahydrate USDMF includes data on Di(morphine) dihydrogen sulfate pentahydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Di(morphine) dihydrogen sulfate pentahydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Di(morphine) dihydrogen sulfate pentahydrate Drug Master File in Korea (Di(morphine) dihydrogen sulfate pentahydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Di(morphine) dihydrogen sulfate pentahydrate. The MFDS reviews the Di(morphine) dihydrogen sulfate pentahydrate KDMF as part of the drug registration process and uses the information provided in the Di(morphine) dihydrogen sulfate pentahydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Di(morphine) dihydrogen sulfate pentahydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Di(morphine) dihydrogen sulfate pentahydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate suppliers with KDMF on PharmaCompass.
A Di(morphine) dihydrogen sulfate pentahydrate CEP of the European Pharmacopoeia monograph is often referred to as a Di(morphine) dihydrogen sulfate pentahydrate Certificate of Suitability (COS). The purpose of a Di(morphine) dihydrogen sulfate pentahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Di(morphine) dihydrogen sulfate pentahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Di(morphine) dihydrogen sulfate pentahydrate to their clients by showing that a Di(morphine) dihydrogen sulfate pentahydrate CEP has been issued for it. The manufacturer submits a Di(morphine) dihydrogen sulfate pentahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Di(morphine) dihydrogen sulfate pentahydrate CEP holder for the record. Additionally, the data presented in the Di(morphine) dihydrogen sulfate pentahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Di(morphine) dihydrogen sulfate pentahydrate DMF.
A Di(morphine) dihydrogen sulfate pentahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Di(morphine) dihydrogen sulfate pentahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Di(morphine) dihydrogen sulfate pentahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Di(morphine) dihydrogen sulfate pentahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Di(morphine) dihydrogen sulfate pentahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Di(morphine) dihydrogen sulfate pentahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Di(morphine) dihydrogen sulfate pentahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Di(morphine) dihydrogen sulfate pentahydrate suppliers with NDC on PharmaCompass.
Di(morphine) dihydrogen sulfate pentahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Di(morphine) dihydrogen sulfate pentahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Di(morphine) dihydrogen sulfate pentahydrate GMP manufacturer or Di(morphine) dihydrogen sulfate pentahydrate GMP API supplier for your needs.
A Di(morphine) dihydrogen sulfate pentahydrate CoA (Certificate of Analysis) is a formal document that attests to Di(morphine) dihydrogen sulfate pentahydrate's compliance with Di(morphine) dihydrogen sulfate pentahydrate specifications and serves as a tool for batch-level quality control.
Di(morphine) dihydrogen sulfate pentahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Di(morphine) dihydrogen sulfate pentahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Di(morphine) dihydrogen sulfate pentahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Di(morphine) dihydrogen sulfate pentahydrate EP), Di(morphine) dihydrogen sulfate pentahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Di(morphine) dihydrogen sulfate pentahydrate USP).